InvestorsHub Logo
Followers 12
Posts 1021
Boards Moderated 0
Alias Born 06/07/2012

Re: None

Thursday, 02/14/2013 6:29:26 PM

Thursday, February 14, 2013 6:29:26 PM

Post# of 158400
CHECK THIS OUT........MEDISTEM SUPPLY ENTB WITH THAT SAME CELL endometrial regenerative cells....NOW READ THIS...MediStem

Ischemia -- the lack of blood flow -- produces heart pain and actual heart attacks. When ischemia takes place in limbs, they may require amputation. To restore blood circulation before it's too late, San Diego-based MediStem is testing a special type of stem cell to make new and sturdy blood vessels.

These cells, called endometrial regenerative cells, are derived from menstrual blood. They don't cause an allergic reaction so they're not rejected, said Alan Lewis, the company's CEO.

"We call them nature's regenerative powerhouse," Lewis said. The cells reproduce prolifically and are very good at creating new blood vessels. The U.S. Food and Drug Administration has approved their use for clinical trials.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.